Published in Vaccine Weekly, November 1st, 1999
After transducing dendritic cells (DC) with a human wild-type p53 containing recombinant adenovirus (Ad-p53), the researchers report that 48 hours after infection approximately half of the DCs transduced expressed p53 protein.
"Mice immunized twice with Ad-p53 DC developed substantial cytotoxic T-lymphocyte (CTL) responses against tumour cells expressing wild-type and different mutant human and murine p53 genes. Very low CTL responses were observed against target cells infected with control adenovirus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly